Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Current Assets: 2011-2019

Historic Current Assets for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $48.4 million.

  • EyePoint Pharmaceuticals' Current Assets rose 173.67% to $48.4 million in Q1 2019 from the same period last year, while for Mar 2019 it was $48.4 million, marking a year-over-year increase of 173.67%. This contributed to the annual value of $39.9 million for FY2018, which is 124.97% up from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Current Assets stood at $48.4 million for Q1 2019, which was up 1.62% from $47.6 million recorded in Q4 2018.
  • EyePoint Pharmaceuticals' Current Assets' 5-year high stood at $57.6 million during Q3 2018, with a 5-year trough of $12.5 million in Q3 2017.
  • Moreover, its 3-year median value for Current Assets was $17.7 million (2017), whereas its average is $30.2 million.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 51.95% in 2017, then surged by 359.41% in 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Current Assets (Quarterly) stood at $21.9 million in 2015, then fell by 15.22% to $18.5 million in 2016, then declined by 26.38% to $13.6 million in 2017, then skyrocketed by 248.85% to $47.6 million in 2018, then skyrocketed by 173.67% to $48.4 million in 2019.
  • Its last three reported values are $48.4 million in Q1 2019, $47.6 million for Q4 2018, and $57.6 million during Q3 2018.